Loading insider details...
Latest Form 4 (Aug 12, 2026): Grant/Award of 175,000 ANNX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Annexon, Inc. (ANNX) | Grant/Award | 175,000 | n/a |
| Jun 13, 2024 | KALA BIO, Inc. (KALA) | Grant/Award | 1,400 | n/a |
| Jun 24, 2023 | Kala Pharmaceuticals, Inc. (KALA) | Grant/Award | 3,784 | n/a |
| Jun 3, 2023 | Kala Pharmaceuticals, Inc. (KALA) | Other (see footnotes) | 3 | n/a |
| Jun 17, 2022 | Kala Pharmaceuticals, Inc. (KALA) | Grant/Award | 40,000 | n/a |
| Nov 18, 2021 | Kala Pharmaceuticals, Inc. (KALA) | Grant/Award | 157,765 | n/a |